Research & Education

IASLC Lung Cancer Grand Rounds: Advances in Lung Cancer Imaging

August 16, 2016 at 9:00PM EDT - Recording Available
 Lauren Averett Byers  

Brett W. Carter, MD
Assistant Professor
Director, Thoracic CT
Co-Director, Thoracic MRI
Co-Lead, PET/CT
The University of Texas MD Anderson Cancer Center
Department of Diagnostic Radiology

Ramaswamy Govindan, MD - Program Chair
Co-Director, Section of Medical Oncology
Professor of Medicine
Anheuser-Busch Endowed Chair in Medical Oncology
Director, Section of Oncology
Washington University School of Medicine 

Name of Reviewer(s): 


Laurie Gaspar, MD, PhD- Advisory Board/Honoraria: Astrazeneca.


Name of Planner(s): 


Pia Hirsch-Nothing to Disclose      Carlos Ferreira-Nothing to Disclose

Name of Activity: 


IASLC Lung Cancer Grand Rounds: Advances in Lung Cancer Imaging

Date of Activity:




COI Resolution: Ensure a balanced discussion of alternative. Do not use trade names. Do not refer to company names or logos. Do not recommend therapies.

“All planning committee members’ and/or faculty’s identified conflicts of interest pertaining to this activity were resolved prior to the activity.”

Speaker: Brett W. Carter, MD- Nothing to Disclose

Moderator: Ramaswamy Govindan, MD - Speakers or Advisory Board , Honoraria and consulting with the following: BI, GSK, Celgene, Roche, Bayer, Genentech, Clovis, Helsinn Healthcare, ARAID Pharmaceuticals, Astellas; Honoraruim with the following: Baxalta, Roche

Type of Activity:

 Live Course

  Internet Live Course (Webinar)XXXX

 Internet Enduring Material

Are there Commercial Supporters for this activity?


If yes, please list:

This live session of IASLC Lung Cancer Grand Rounds features Dr. Brett Carter.  This presentation will discuss the role of advanced imaging techniques in evaluating lung cancer, including:

  • Dual-energy computed tomography (DECT)
  • Magnetic resonance (MR) imaging
  • FDG positron emission tomography (PET)/CT
  • The current state and potential impact of advanced imaging analytics such as CT texture analysis (CTTA) in assessing lung cancer.      

After attending this program, participants will:

  • Recognize  the role of advanced imaging techniques in evaluating lung cancer.
  • Examine evolving state-of-the art of lung cancer imaging.
  • Demonstrate current state of advanced imaging analytics in assessing lung cancer.

Following the presentation, there will be ample time for discussion and a question/answer session.  Attendees will be able to submit questions and comments to Dr. Carter via internet chat

This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants. 



IASLC Financial/Commercial Relationships and Conflicts of Interest Policy

IASLC Honoraria Policy

IASLC Commercial Support Agreement (LOA)

Please complete the evaluation link provided to you after the activity. The Certificate of credit will be ready for you to print or save for your records.

IASLC Lung Cancer Grand Rounds webinars will continue throughout 2016. The goal is to hold one program monthly. Participants who complete a pre-and post-test along with an evaluation will receive 1 AMA PRA Category 1 CreditTM for each completed webinar.

Use the Time Zone Converter